Altered neuronal network and rescue in a human MECP2 duplication model.
Altered neuronal network and rescue in a human MECP2 duplication model.
复制标题
DOI:
10.1038/mp.2015.128
复制
发表时间:
2016-02
影响因子:
11
通讯作者:
Muotri AR
中科院分区:
文献类型:
--
作者:
Nageshappa S;Carromeu C;Trujillo CA;Mesci P;Espuny-Camacho I;Pasciuto E;Vanderhaeghen P;Verfaillie CM;Raitano S;Kumar A;Carvalho CM;Bagni C;Ramocki MB;Araujo BH;Torres LB;Lupski JR;Van Esch H;Muotri AR
Increased dosage of MeCP2 results in a dramatic neurodevelopmental phenotype with onset at birth. We generated induced pluripotent stem cells (iPSC) from patients with the MECP2 duplication syndrome (MECP2dup), carrying different duplication sizes, to study the impact of increased MeCP2 dosage in human neurons. We show that cortical neurons derived from these different MECP2dup iPSC lines have increase synaptogenesis and dendritic complexity. Additionally, using multi-electrodes arrays, we show that neuronal network synchronization was altered in MECP2dup-derived neurons. Given MeCP2 function at the epigenetic level, we tested if these alterations were reversible using a library of compounds with defined activity on epigenetic pathways. One histone deacetylase inhibitor, NCH-51, was validated as a potential clinical candidate. Interestingly, this compound has never been considered before as a therapeutic alternative for neurological disorders. Our model recapitulates early stages of the human MECP2 duplication syndrome and represents a promising cellular tool to facilitate therapeutic drug screening for severe neurodevelopmental disorders.